RE

Regeneron Pharmaceuticals IncNASDAQ REGN Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

124.33

Mega

Exchange

XNAS - Nasdaq

View Full Company Analysis

Return on invested capital ROIC

23 %

Last period ROIC

-2%

ROIC has decreased in 5 years


What is ROIC ?

The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.

What is ROIC ?

The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.

What is ROIC of Regeneron ?

Regeneron`s ROIC for the last twelve months ended 2024-06-30 is 23 %

View Full Company Analysis